Science Explorer Back to mapMap

Most cited papers from Scholar Rock (United States)

What are the most cited papers from Scholar Rock (United States)?

The most cited paper from Scholar Rock (United States) is "Antibodies to watch in 2020" (Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider et al., 2019), with 442 citations. Next come "Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape" (232) and "Advances and limitations for the treatment of spinal muscular atrophy" (138).

Showing 50 of 62 papers. Every paper with more than 3 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Antibodies to watch in 2020 Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider et al. · mAbs Open access 18 Dec 2019 442
2 Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape Constance J. Martin et al. · Science Translational Medicine 25 Mar 2020 232
3 Advances and limitations for the treatment of spinal muscular atrophy John W. Day, Kelly Howell, Amy Place et al. · BMC Pediatrics Open access 3 Nov 2022 138
4 Infectious Disease as an Evolutionary Paradigm Joshua Lederberg · Emerging infectious diseases Open access Dec 1997 123
5 Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy Kimberly K. Long, Karen M. O’Shea, Ramzi J. Khairallah et al. · Human Molecular Genetics Open access 7 Nov 2018 112
6 Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis Alan C. Chen, Adriana Donovan, Renée M. Ned et al. · Proceedings of the National Academy of Sciences Open access 31 Aug 2015 98
7 Blocking extracellular activation of myostatin as a strategy for treating muscle wasting Michelle Pirruccello, Justin Jackson, Stefan Wawersik et al. · Scientific Reports Open access 29 Jan 2018 94
8 Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. Julio Roberto Cáceres‐Cortés, Daniel Rajotte, J. Dumouchel et al. · Journal of Biological Chemistry Open access Apr 1994 88
9 Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3 Thomas O. Crawford, Basil T. Darras, John Day et al. · Neurology Open access 8 Feb 2024 53
10 A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy Doreen Barrett, Sanela Bilic, Yung H. Chyung et al. · Advances in Therapy Open access 8 May 2021 47
11 Rare deleterious mutations of the gene EFR3A in autism spectrum disorders Abha R. Gupta, Michelle Pirruccello, Feng Cheng et al. · Molecular Autism Open access 2014 42
12 Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants Alain Beck, Christine Nowak, Deborah Meshulam et al. · Antibodies Open access 20 Nov 2022 41
13 Measuring Soil Electrical Resistivity Using a Resistivity Box and a Resistivity Probe Sekharan Sreedeep, A.C. Reshma, Devendra Narain Singh · Geotechnical Testing Journal 25 May 2004 40
14 Stability of Protein Pharmaceuticals: Recent Advances Mark Cornell Manning, Ryan E. Holcomb, R. W. Payne et al. · Pharmaceutical Research 27 Jun 2024 37
15 Tolloid cleavage activates latent GDF8 by priming the pro‐complex for dissociation Viet Q. Le, Roxana E. Iacob, Yuan Tian et al. · The EMBO Journal Open access 17 Jan 2018 35
16 Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma et al. · mAbs Open access 2021 34
17 Federated Learning and Data Privacy: A Review of Challenges and Opportunities Praveen Kumar Myakala, Chiranjeevi Bura, Anil Kumar Jonnalagadda · International Journal of Research Publication and Reviews Open access Dec 2024 32
18 Recent Studies of Image and Soft Computing Techniques for Plant Disease Recognition and Classification Hiteshwari Sabrol, Satish Kumar · International Journal of Computer Applications Open access 17 Sep 2015 32
19 Characterization of Binding Mode of Action of a Blocking Anti-Platelet-Derived Growth Factor (PDGF)-B Monoclonal Antibody, MOR8457, Reveals Conformational Flexibility and Avidity Needed for PDGF-BB To Bind PDGF Receptor-β Jun Kuai, Lidia Mosyak, Jonathan C.W. Brooks et al. · Biochemistry 24 Feb 2015 32
20 FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models Timothy Weeden et al. · Communications Medicine Open access 18 Jan 2025 31
21 Neutralizing Antibody Validation Testing and Reporting Harmonization Heather A. Myler et al. · The AAPS Journal Open access 8 Jul 2023 30
22 Population pharmacokinetics and exposure–response of anti‐programmed cell death protein‐1 monoclonal antibody dostarlimab in advanced solid tumours Murad R. Melhem, Eva Hanze, Sharon M. Lu et al. · British Journal of Clinical Pharmacology Open access 31 Mar 2022 29
23 CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy CYNTHIA M. ARBEENY, Hong Ling, Mandy M. Smith et al. · Journal of Pharmacology and Experimental Therapeutics Open access 21 Mar 2019 29
24 Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial Thomas O. Crawford et al. · The Lancet Neurology Open access 13 Aug 2025 28
25 Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors Brian T. Welsh, Ryan Faucette, Sanela Bilic et al. · International Journal of Toxicology Open access 19 Mar 2021 27
26 Structural basis of specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015 Kevin B. Dagbay, Erin Treece, Frederick C. Streich et al. · Journal of Biological Chemistry Open access 20 Feb 2020 27
27 An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis Justin Jackson et al. · Science Signaling 9 Jul 2024 23
28 2D-LC–MS/MS to Measure Cleaved High-Molecular-Weight Kininogen in Human Plasma as A Biomarker for C1-Inh-Hae Guodong Zhang, Daniel J. Sexton, Ryan Faucette et al. · Bioanalysis Open access Oct 2017 23
29 The effect of nitrogen on cereal yields E. R. Bullen, W. J. Lessells · The Journal of Agricultural Science Oct 1957 22
30 Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab Beth Hutchins et al. · Molecular Cancer Therapeutics 30 Mar 2020 21
31 Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study Thomas O. Crawford, John W. Day, Darryl C. De Vivo et al. · Frontiers in Neurology Open access 22 Jul 2024 20
32 An Integrated Analysis of Dostarlimab Immunogenicity Sharon M. Lu, Ronald R. Bowsher, Amanda Clancy et al. · The AAPS Journal Open access 29 Jul 2021 18
33 Cigarette Smoking in a Cohort of Sydney Schoolchildren: 1971-1974 Stephen Leeder, JENNIFER K. PEAT, Ann J. Woolcock et al. · Australian and New Zealand Journal of Medicine Oct 1977 13
34 Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development Timothy Anthony Yap, Zsofia Kinga Stadler, Leigh Anne Stout et al. · American Society of Clinical Oncology Educational Book Jun 2023 12
35 Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease Brian T. Welsh, Shaun M. Cote, Deborah Meshulam et al. · International Journal of Toxicology Open access Jul 2021 11
36 Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial Richard E. Pratley, Douglas Scott Denham, Rupal Trivedi et al. · Nature Medicine Open access 8 Jun 2026 10
37 Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial Timothy A. Yap, Randy F. Sweis, Ulka Vaishampayan et al. · Nature Medicine Open access 13 Jan 2026 8
38 Presynapses are mitophagy pit stops that prevent axon degeneration Wai Kit Lam, Runa S. J. Lindblom, Bridget Milky et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 9 Sep 2024 8
39 A Review On Google Earth Engine: An Open Access Cloud Analysis Platform For Planetary Scale Satellite Data Rohini Sangeetham, Nagamuthu Krishnan S S · E3S Web of Conferences Conference paperOpen access 2024 6
40 A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation Shaun M. Cote, Justin Jackson, Michelle Pirruccello et al. · SLAS DISCOVERY Open access 26 Jul 2019 6
41 Comparative Study of Parallel Programming Models to Compute Complex Algorithm Mukul Mani Sharma, Pradeep Soni · International Journal of Computer Applications Open access 18 Jun 2014 6
42 Remaining Burden of Spinal Muscular Atrophy Among Treated Patients: A Survey of Patients and Caregivers Julie A. Parsons, Natalie Land, Melissa Culhane Maravić et al. · Annals of Clinical and Translational Neurology Open access 6 Jul 2025 5
43 Effect of Pranayama and Meditation on Emotional Intelligence among Undergraduate Students: A Randomized Controlled Study Jairam Kushwaha, Vatsala Thapliyal, Sachin Kumar Sharma et al. · International Journal of Ayurvedic Medicine Open access 10 Jul 2024 5
44 Selective Myostatin Inhibition Spares Sublesional Muscle Mass and Myopenia-Related Dysfunction after Severe Spinal Cord Contusion in Mice Gregory E. Bigford, Adriana Donovan, Micah T. Webster et al. · Journal of Neurotrauma 29 Oct 2021 5
45 Assessment of Water Quality of Tighra Reservoir using Weighted Arithmetic Water Quality Index (WA-WQI) Rishabh Kumar, Jay Singh Rajput, Abhishek Kumar Saxena · International Journal of Innovative Science and Research Technology (IJISRT) Open access 29 May 2024 4
46 Roadways Wind Turbine Technology Raja Kumar, Pankaj Kumar, Pritam meena et al. · Journal of Nonlinear Analysis and Optimization Theory & Applications (JNAO) Open access 2023 4
47 Caste, gender, and labour: A case study of dalit women domestic workers Aishwarya Arora · International Journal of Political Science and Governance Open access Jul 2023 4
48 Quantitative Analysis of Document Stored Databases Pradeep Soni, Narendra Singh Yadav · International Journal of Computer Applications Open access 19 May 2015 4
49 Physico-Chemical Analysis of Sugar Mill Effluent of Kabirdham (C.G.) Chhaya Bhatt, Rashmi Verma · International Journal of Scientific Engineering and Research Open access 27 Oct 2016 3
50 No idle flow shop scheduling models with separated set-up times and concept of job weightage to optimize rental cost of machines Shakuntala Singla, Harshleen Kaur, Deepak Gupta et al. · Journal of Project Management Open access 2024 3

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.